SuperworthAlphatec profit margin ATEC
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- −13.5%
- Operating margin, 12 months
- −6.0%
- Net margin on a year earlier
- +10.8 pts
- Peer median
- 7.3%
Over the twelve months to Jun 30, 2026, Alphatec kept −13.5% of its revenue as net profit, with an operating margin of −6.0% and a gross margin of 70.8%.
Five years earlier its net margin was −54.1%.
The median for 10 medical instruments and supplies stocks of a similar size is 7.3%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −18.8% | −10.7% | 69.6% |
| FY2024 | −26.5% | −22.3% | 69.4% |
| FY2023 | −38.7% | −36.0% | 64.3% |
| FY2022 | −43.1% | −41.9% | 66.4% |
| FY2021 | −59.3% | −52.7% | 64.9% |
| FY2020 | −54.5% | −40.6% | 70.8% |
| FY2019 | −50.3% | −41.7% | 68.4% |
| FY2018 | −31.6% | −24.5% | 69.0% |
| FY2017 | −2.3% | −8.8% | 61.3% |
| FY2016 | −24.9% | −12.8% | 63.3% |
| FY2015 | n/a | n/a | 65.5% |
| FY2014 | −6.2% | 0.9% | 69.3% |
| FY2013 | −40.2% | −35.9% | 60.7% |
| FY2012 | −7.9% | −5.0% | 63.1% |
| FY2011 | −11.2% | −12.4% | 59.1% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −13.5% | +10.8 pts | −6.0% | |
| Q1 FY26 | −15.9% | +9.8 pts | −7.7% | |
| Q4 FY25 | −18.8% | +7.7 pts | −10.7% | |
| Q3 FY25 | −21.3% | +9.8 pts | −13.3% | |
| Q2 FY25 | −24.3% | +9.2 pts | −16.8% | |
| Q1 FY25 | −25.8% | +11.7 pts | −21.3% | |
| Q4 FY24 | −26.5% | +12.2 pts | −22.3% | |
| Q3 FY24 | −31.1% | +7.2 pts | −27.4% | |
| Q2 FY24 | −33.5% | +6.0 pts | −30.0% | |
| Q1 FY24 | −37.4% | +1.7 pts | −34.5% | |
| Q4 FY23 | −38.7% | +4.4 pts | −36.0% | |
| Q3 FY23 | −38.3% | +10.9 pts | −36.3% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Alphatec's size, closest first, today.
| Company | Profit margin |
|---|---|
| ATECAlphatec | −13.5% |
| LMATLemaitre Vascular | 25.0% |
| EYENational Vision | 2.5% |
| INSPInspire Medical Systems | 15.0% |
| UFPTUFP Technologies | 11.4% |
| CDRECadre | 5.3% |
| BVSBioventus | 9.4% |
| STAAStaar Surgical | 1.1% |
| IRMDIradimed | 26.7% |
| ATRCAtriCure | 1.9% |
| WRBYWarby Parker | 0.8% |
| Peer median | 7.3% |
Where Alphatec ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Alphatec
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.